Since the initial development of the "passage A" mouse leukemia virus in 1957, this virus has been propagated in our laboratory by serial passage in newborn C3H(f) mice. At the present time, 10-2-10-3 dilutions in physiological saline solution of this mouse-passaged virus induce lymphatic leukemia in practically all inoculated mice after a latency of 3-5 months. On the other hand, when the same virus was propagated on NIH 3T3 mouse embryo cells in tissue culture for more than 10 years, its leukemogenic potency became considerably reduced. Recent bioassay experiments carried out in our laboratory demonstrated that after such prolonged propagation in tissue culture this virus now inducedileukemia in less than 15% of the inoculated suckling C3H(f) mice; only undiluted or 10% dilutions of the tissue culture fluid (very occasionally 10-2 or 10-3 dilutions) induced leukemia after a prolonged latency varying from 5.5 to 18 months. The passaged and the tissueculture-grown virus strains are identical immunologically and indistinguishable in their morphology when examined by electron microscopy. The tissue-culture-grown virus, attenuated in its leukemogenic potency, does not, however, confer immunity against a challenge with the mouse-passaged virus.
Since the mouse leukemia passage A virus was originally isolated from Ak spontaneous leukemia (1) it has been passed serially in newborn C3H(f) mice by cell-free transfer for over 20 years; it is now in its current 99th serial passage. During that time it has retained its full leukemogenic potency. However, results of experiments reported in this study suggest that when the same virus has been passed serially on mouse embryo cells in tissue culture for over 10 years, it has lost to a considerable extent its ability to induce leukemia on bioassay. In this respect, the mouse leukemia virus seems to be similar to certain other leukemogenic viruses in mice and chickens that have lost their oncogenic potency after prolonged passage in tissue culture (2) (3) (4) (5) (6) .
MATERIALS AND METHODS Animals. C3H(f) mice bred in our laboratory for more than 25 years by brother-to-sister mating were used. Newborn or suckling mice up to 7 days old were inoculated subcutaneously or intraperitoneally.
Virus Maintained by Mouse-to-Mouse Passage. Passage A mouse leukemia virus (Gross) has been maintained in our laboratory by serial cell-free transfer in C3H(f) mice since its original isolation in 1957 from spontaneous Ak leukemia (1) . As soon as the inoculated mice developed leukemia, usually after a latency varying from 3 to 4 months, they were used as donors for the preparation of extracts serving for the subsequent transfer of the virus. At the present time, the virus is in its 99th serial transfer.
Preparation of Cell-Free Extracts. (7) .
For all lots of tissue-culture-grown virus, the product characterization sheets received with the lots gave the virus particle counts and protein concentrations. The virus particle concentrations varied in five different lots from 1.2 to 2.3 X 1011 virus particles per ml. RESULTS Leukemogenic Potency of Mouse Leukemia Virus Maintained by Mouse-to-Mouse Passage. When tested in our current studies, the mouse leukemia passage A virus induced leukemia in 9 out of 10 C3H(f) mice (90%) inoculated with the 10-2 virus filtrate dilution and in 80% of mice inoculated with a 10-3 dilution ( Table 1 ). The leukemogenic potency of the passage A virus was similar, or only slightly lower, when the same virus was tested for its leukemogenic potency about 20 years earlier. After its initial isolation from spontaneous Ak mouse leukemia, the passage A mouse leukemia virus, when tested in its 7th and 8th initial serial passage in 1957, induced leukemia in 100% of newborn C3H(f) mice inoculated with a 20% virus filtrate (1). When tested 3 years later, in its 13th and 14th serial passage, it induced leukemia in 75% of C13H(f) mice inoculated with the lo-2 dilution of virus filtrate and in 41% 
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Leukemia induced with the tissue-culture-passaged virus was in all respects similar to that induced with the virus passaged in mice. The gross pathological and microscopic pictures were the same (Figs. 1 and 2 ). Proc. Natl. Acad. Sci. USA 75 (1978) 3991 particles (Fig. 3) , indistinguishable from those previp9s de- scribed in virus-induced mouse leukemia (9, 10), were o on electron microscopic examination in organs of mice that developed leukemia after inoculation of the tissue-culturepassaged virus. The number of virus particles observed in leukemic tissues was also comparable to that observed in organs of mice or rats with leukemia induced with passage A (Gross) mouse leukemia virus (7, 10) . Lack of Resistance of Mice Inoculated with Tissue-Culture-Grown Virus to Subsequent Challenge with MousePassaged Virus. In view of the fact that after tissue culture passage the virus failed to induce leukemia in the majority of inoculated mice, an attempt was made to determine whether such mice did not develop resistance to reinoculation with the mous-passaged virus.
jn thi § series of experiments, 3-to 4-day-old suckling C3H(f) mf were inoculated with the tissue-culture-passaged virus (0.3 ml subcutaneously each). These mice received booster inoculations with a similar dose of the same virus after 6 and 13 days.
Seven days later, they were challenged by inoculation with the mouse-passaged virus (0.5 ml of a 10% virus filtrate, intraperitoneally, each). Control mice received only a similar dose of the challenge inoculation. All mice in both groups developed leukemia (Table 3) . DISCUSSION Results of experiments reported in this study suggest that the mouse leukemia virus originally isolated in our laboratory from spontaneous Ak leukemia has not lost its ability to induce leukemia on bioassay in practically all inoculated mice after serial (6) , is being used as an efficient vaccine against this disease (12) .
Under experimental conditions used in a single preliminary experiment, we have observed no immunity resulting in mice from inoculation of the tissue-culture-grown mouse leukemia virus after its serial passage in mouse embryo cells for over 10 years. It remains to be determined, however, whether the mouse leukemia virus would not retain at least some immunological potential at a different tissue-culture-passage level than that used in this study.
